Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (Infliximab) treatment for Crohn's disease: A case report

M. Principi, A. Di Leo, M. Ingrosso, A. Pisani, S. Marangi, A. Amoruso, C. Panella, A. Francavilla, Enzo Ierardi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (Infliximab) treatment for Crohn's disease: A case report'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds